	Upregulation of NKAIN1 Predicts Poor Prognosis and Shapes Immune Infiltration in Uterine Corpus Endometrial Carcinoma: An Integrated Bioinformatic and Experimental Study. Anticancer Agents Med Chem Chang R, Wu Y, Cui A, Jiang L, Jia Q. PMID: 42973342 [PubMed - as supplied by publisher]
	Long-Term Predictive Value of MRI Radiomics in Identifying Patients with Metastasis-Free Breast Cancer Over a 100-Month Follow-Up Period: A retrospective, observational study. Curr Med Imaging Zhao YS, Ji Y, Li YB, Wang YH, Ma XX, Wang JB, Wang P, Lu H. PMID: 42973335 [PubMed - as supplied by publisher]
	Preventive Effects of MÄnuka Honey and a Honey Sugar Analogue on Breast Cancer Development: Modulation of Oxidative Stress and AKT/mTOR Signaling in a Rat Model. Curr Top Med Chem Usama M, Abas AM, Abd Elhameed HAH. PMID: 42973300 [PubMed - as supplied by publisher]
	A multi-reader multi-case study comparing Breast Cancer Reading Efficiency and Accuracy in Screening with Tomosynthesis versus AI-assisted mammography. Br J Radiol Ning SGS, Hao D, Chandrasegan G, Yuan Zheng L, Chua W, Ong HY, Seah E, Ge S, Lau S, Wong YM, Jagmohan P, Trivedi H, Brown-Mulry B, Isaac RS, Gichoya JW, Mansuri A, Feng M, Tai BC, Hartman M. PMID: 42973140 [PubMed - as supplied by publisher]
	Concentration-Based Short-Course Hyperthermic IntraPEritoneal Chemotherapy (HIPEC) at Interval Cytoreductive Surgery (iCRS) for Advanced Ovarian Cancer: Final Analysis of Overall Survival in a Phase 2 Trial. J Surg Oncol Batista TP, de Barros ABD, Carneiro VCG, Tancredi R, Badiglian-Filho L, Costa RLR, Lopes A, Sarmento BJQ, Leão CS. PMID: 42973117 [PubMed - as supplied by publisher]
	Prediction of pathologic complete response in breast cancer patients undergoing neoadjuvant chemotherapy using baseline 18F-FDG PET/CT-derived CT radiomics and clinicopathological biomarkers. Nucl Med Commun Hatipoglu F, Senmevsim O, Kahraman EG, Tasli F. PMID: 42973046 [PubMed - as supplied by publisher]
	Reminder recall is associated with higher mammogram uptake among overdue repeat screeners: an exploratory telephone survey within a randomized trial. BMC Med Lucky SS, Li W, Ow SGW, Loh L, Tan JH, Goh BC, Lee SC. PMID: 42972567 [PubMed - indexed for MEDLINE]
	Multicenter development and validation of a serum microRNA-based diagnostic model for breast cancer and its association with tumor burden and biological aggressiveness: an observational case-control study. Breast Cancer Res Yamaguchi A, Kawanishi K, Ishii K, Fukui Y, Shimizu H, Kawashima M, Otomo R, Taniguchi S, Hirai M, Tsuji W, Takahara S, Yamashiro H, Yanai H, Moriguchi Y, Tsuyuki S, Nishie M, Suwa H, Masuda N, Toi M. PMID: 42972452 [PubMed - indexed for MEDLINE]
	Explainable machine learning and multi-layer transcriptomic analysis identify and validate prognostic biomarkers for breast cancer survival. BMC Med Genomics Oguz O, Ayd, Gungor BB, Goksuluk D. PMID: 42972374 [PubMed - indexed for MEDLINE]
	Primary ovarian insular carcinoid in an infertile woman managed with fertility preservation: a case report. BMC Womens Health Mohammadzadeh M, Mansour H, Ghahghaei-Nezamabadi A, Kashani L, Tehranian A, Alaeii M, Ebadi M, Hajialigol A. PMID: 42972323 [PubMed - indexed for MEDLINE]
	Family history and stage at diagnosis but not prognosis in female breast cancer: a large registry-based cohort study from Iran. BMC Cancer Azizi S, Hosseinpour Z, Akbari A, Akbari ME. PMID: 42972306 [PubMed - indexed for MEDLINE]
	Prognostic factors of synchronous endometrial and ovarian cancers: a systematic review and meta-analysis of cohort studies. BMC Cancer Zendehdel H, Teymoordash SN, Kashian M. PMID: 42972281 [PubMed - indexed for MEDLINE]
	Integrated typing system of endometrial cancer based on Chinese population - PKU typing: a retrospective, multicentre study. BMC Cancer Li L, Luo D, Li H, Li X, Cheng Y, Zhou J, You X, Dai Y, Jiang X, Zhai Y, Wang J, Zhang X, Han B, Kong W, Dong Y, Wang J. PMID: 42972275 [PubMed - indexed for MEDLINE]
	Papillary neoplasms of the breast: Practical diagnostic updates and emerging concepts. Virchows Arch Rakha EA. PMID: 42972084 [PubMed - as supplied by publisher]
	Efficacy and safety of palbociclib in older women with advanced HR-Positive/HER2-negative breast cancer: a systematic review and meta-analysis. Expert Opin Pharmacother de Moraes FCA, Tanimoto LE, de Paiva FA, Dups Talah BA, Cristina Beckert H, Becerra-Galindo BS, Figueroa Magalhães MC. PMID: 42971928 [PubMed - as supplied by publisher]
	Follow-up after fertility-sparing surgery for cervical cancer: should human papillomavirus testing be used routinely? A narrative review. Int J Gynecol Cancer Viveros-Carreño D, Beshar I, Mora-Soto N, Cruz C, Alvarenga-Bezerra V, Fernandes A, Pareja R, Plante M. PMID: 42971711 [PubMed - indexed for MEDLINE]
	Biogenic gold nanoparticles in breast cancer nanomedicine: sustainable synthesis, multifunctional engineering, and the road to clinical translation. Int J Pharm Singh UR, Mishra G, Leharwani M, Abourehab MAS, Gupta G, Wen Goh K, Kesharwani P. PMID: 42971495 [PubMed - as supplied by publisher]
	Breast cancer cellular and gene-based therapies: current approaches, clinical results, and future perspectives. Crit Rev Oncol Hematol Dönmez H. PMID: 42971290 [PubMed - as supplied by publisher]
	Effects of insulin resistance on pregnancy outcomes and complications in women with polycystic ovary syndrome. J Int Med Res Hua Z, Shen L, Chen WN. PMID: 42971262 [PubMed - indexed for MEDLINE]
	Phase II study of magrolimab combination therapies in patients with advanced triple-negative breast cancer. ESMO Open Park YH, Rugo HS, Chittoria N, Sacks R, Chiu J, Murphy C, Ayodele O, Kim GM, Lee KS, Xu W, Joshi R, Kwong A, Dong M, Zhang Y, Rong R, Lopez Rodrigo E, Rainey N, Adams S. PMID: 42970861 [PubMed - as supplied by publisher]

Articles 1 - 20 / 337492

Page 1 of 16875



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy